Bausch + Lomb Corporation (TSX:BLCO)

Market Cap	5.55B
Revenue (ttm)	6.94B
Net Income (ttm)	-520.32M
Shares Out	n/a
EPS (ttm)	-1.48
PE Ratio	n/a
Forward PE	19.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,653
Average Volume	4,658
Open	16.50
Previous Close	15.78
Day's Range	16.50 - 16.95
52-Week Range	14.56 - 29.37
Beta	0.54
RSI	45.88
Earnings Date	Apr 30, 2025

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during heal...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1853
• Employees: 13,500
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BLCO

Financial Performance

In 2024, Bausch + Lomb's revenue was $4.79 billion, an increase of 15.56% compared to the previous year's $4.15 billion. Losses were -$317.00 million, 21.9% more than in 2023.

Financial numbers in USD